Swan EndoSurgical has named longtime Stryker executive Erik Todd as CEO, signaling a major push to commercialize its flexible endoluminal surgical robotics platform. Backed by Revival Healthcare Capital and Olympus, the company aims to reshape advanced GI intervention with fully integrated robotic technology — targeting procedures that today remain complex, invasive, and costly. Todd’s arrival brings 25+ years of robotics leadership as Swan prepares for its next scale phase.
Keep Reading
Add A Comment
